BioCentury
ARTICLE | Company News

Genzyme Transgenics reacquires rights

October 2, 2000 7:00 AM UTC

GZTC reacquired Asian rights from Sumitomo to its technology for the production of therapeutic proteins in milk for 333,334 shares valued at $11.8 million based on GZTC's Sept. 29 closing price. As a ...